ATTD 2024 - 17th International Conference on Advanced Technologies & Treatments for Diabetes

Dear Colleagues,

On behalf of the Organizing Committee, we are delighted to welcome you to the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2024) to be held on 6-9 March 2024 in Florence, Italy.

We invite you to be a part of ATTD – the leading international forum – where clinicians, diabetes care providers, researchers, industries, start-up, investors, reimbursement authorities, regulators and people with diabetes, assemble with the goal to ameliorate the care of people with diabetes as the fastest possible pace.

Presentations and discussions will be given by many distinguished professionals in the field and will include topics such as artificial intelligence-based decision support systems, glucose sensors, closed-loop systems, artificial pancreas, devices for diabetic prevention, new medications for the treatment of diabetes, new insulins, delivery systems and insulin pumps and many more.

ATTD 2024 promises to be an outstanding event and we will be happy to meet you in the magnificent city of Florence.

Yours sincerely,

Professor Moshe Phillip | Professor Tadej Battelino
Conference Chairpersons

In-Person Participation Fees (in EUR) apply to payments received prior to the indicated deadlines.

Online Participation Fees (in EUR) apply to payments received prior to the indicated deadlines.

* Proof of Student/Fellow/Nurse/Dietitian status is mandatory – In order to benefit from the special fee, a submission of your status confirmation (approval letter signed by the Head of Department or copy of your status ID) must be uploaded during the Online registration.

** FLEX Want to attend in-person, but concerned your ability to travel may change? Purchase Flex with your In-Person registration for the freedom to convert to Online registration any time before the meeting and receive a refund of the difference in fees.

EU national legislation and codes of practice prohibit the advertising of prescription-only medicines to individuals not licensed/authorized to prescribe or supply ‘prescription medicines’, apply (Medicines for Europe Code. Article 4.1. Non-promotion of prescription-only medicines).

In order to prevent these groups from being actively approached with advertising, they will be identified as such.

Fees for in-person participants include:

• Participation in all scientific sessions.
• Opening Ceremony and Welcome Reception.
• Access to the Exhibition Area.
• Refreshments during coffee breaks as indicated in the program.
• Dedicated time and place for Networking.
• Delegate bag including all conference printed material
• ATTD 2023 Yearbook Online
• Open access to the ATTD Virtual Platform where Live sessions will be streamed during the conference days. The session recordings will be available, after the conference to ATTD delegates for 3 months, on Unlok. New to ATTD on UNLOK? Please create your free account here.

ATTD is the leading international meeting point where clinicians, diabetes care providers, researchers, industries, investors, reimbursement authorities, and people with diabetes, assemble with the aim of sharing knowledge and developing collaborations.

Presentations and discussions will be given by many distinguished professionals in the field and will include topics such as digital clinics, decision support systems and advisors, big data and artificial intelligence-based decision support systems, glucose sensors, closed- and open-loop systems, artificial pancreas, devices for diabetic prevention, new insulins and new medications, insulin pumps and many more.

Click to review the scientific programme.